TrialJournal of neurology, neurosurgery, and psychiatry1997

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

T Koudriavtseva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.